Free Trial

Achilles Therapeutics (ACHL) Institutional Ownership

Achilles Therapeutics logo
$0.98 +0.00 (+0.01%)
(As of 05:26 PM ET)

Institutional Ownership Changes (13F Filings) for Achilles Therapeutics (NASDAQ:ACHL)

Current
Institutional Ownership
Percentage
56.38%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$9.68M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$3.30M
Get ACHL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Achilles Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ACHL Institutional Buying and Selling by Quarter

Achilles Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/5/2024 BML Capital Management LLC4,100,002$4.18M2.5%+555.8%9.978%
8/12/2024 XTX Topco Ltd51,660$42K0.0%+239.4%0.126%
8/9/2024 Renaissance Technologies LLC682,734$556K0.0%-32.1%1.662%
8/6/2024 Acadian Asset Management LLC250,825$203K0.0%-10.7%0.610%
5/20/2024 Virtu Financial LLC20,947$26K0.0%-47.1%0.051%
5/17/2024 Artal Group S.A.755,375$944K0.0%-66.5%1.894%
5/17/2024 Ikarian Capital LLC1,443,181$1.80M0.2%N/A3.619%
5/15/2024 Baker BROS. Advisors LP1,208,775$1.51M0.0%-42.5%3.031%
5/14/2024 StemPoint Capital LP1,385,750$1.73M0.5%N/A3.475%
5/10/2024 Acadian Asset Management LLC280,929$350K0.0%N/A0.704%
3/7/2024 Fcpm Iii Services B.V.2,390,050$2.13M0.6%N/A5.861%
2/14/2024 Vestal Point Capital LP108,083$96K0.0%N/A0.265%
5/12/2023 Forefront Analytics LLC75,625$72K0.0%+147.7%0.185%
2/14/2023 RA Capital Management L.P.1,607,834$1.45M0.0%-67.9%4.107%
11/14/2022 Point72 Asset Management L.P.2,107,595$4.76M0.0%+18.6%5.383%
11/14/2022 Forefront Analytics LLC32,200$72K0.0%N/A0.082%
8/15/2022 Point72 Asset Management L.P.1,776,744$4.48M0.0%+18.4%4.538%
8/15/2022 Kettle Hill Capital Management LLC242,978$612K0.2%N/A0.621%
2/15/2022 Sender Co & Partners Inc.27,690$139K0.1%N/A0.068%
2/14/2022 Point72 Asset Management L.P.1,000,000$5.01M0.0%+100.0%2.463%
2/11/2022 Syncona Portfolio Ltd11,086,909$55.55M53.1%N/A27.306%
11/15/2021 Point72 Asset Management L.P.500,000$3.90M0.0%N/A1.231%
11/15/2021 Sphera Funds Management LTD.242,500$1.89M0.2%-17.0%0.597%
11/15/2021 AXA S.A.279,454$2.18M0.0%+3.8%0.688%
11/15/2021 Farallon Capital Management LLC450,000$3.51M0.0%-54.8%1.108%
11/12/2021 Affinity Asset Advisors LLC100,000$779K0.2%+25.0%0.246%
8/17/2021 Woodline Partners LP77,386$758K0.0%-67.6%0.191%
8/17/2021 Sphera Funds Management LTD.292,194$2.86M0.2%-2.6%0.719%
8/17/2021 Millennium Management LLC196,144$1.92M0.0%-3.3%0.483%
8/16/2021 RA Capital Management L.P.5,014,687$49.09M0.8%+261.1%12.345%
8/16/2021Pinz Capital Management LP16,423$161K0.0%+164.8%0.040%
8/16/2021 Macquarie Group Ltd.40,402$396K0.0%-26.9%0.099%
8/13/2021 Affinity Asset Advisors LLC80,000$783K0.3%+220.0%0.197%
8/13/2021 AXA S.A.269,135$2.64M0.0%N/A0.663%
8/12/2021 JPMorgan Chase & Co.49,405$484K0.0%-92.1%0.122%
8/12/2021 Monashee Investment Management LLC64,697$633K0.1%-48.2%0.159%
8/6/2021 Sei Investments Co.16,220$159K0.0%N/A0.040%
8/3/2021 Peregrine Capital Management LLC225,669$2.21M0.0%-30.0%0.556%
6/10/2021 Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860%
5/19/2021 Squarepoint Ops LLC28,000$463K0.0%N/A0.069%
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.
5/18/2021 Baker BROS. Advisors LP2,591,366$42.89M0.2%N/A6.379%
5/18/2021 Millennium Management LLC202,785$3.36M0.0%N/A0.499%
5/18/2021 RA Capital Management L.P.1,388,888$22.99M0.3%N/A3.419%
5/18/2021 Orbimed Advisors LLC1,584,845$26.23M0.2%N/A3.901%
5/18/2021 Redmile Group LLC2,088,089$34.56M0.5%N/A5.140%
5/18/2021 Alyeska Investment Group L.P.32,230$533K0.0%N/A0.079%
5/18/2021 Boxer Capital LLC1,536,208$25.42M0.9%N/A3.782%
5/18/2021 Citadel Advisors LLC39,253$650K0.0%N/A0.097%
5/17/2021 Deerfield Management Company L.P. Series C800,000$13.24M0.3%N/A1.969%
5/17/2021 Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860%
5/17/2021 Woodline Partners LP238,822$3.95M0.1%N/A0.588%
5/17/2021 Caas Capital Management LP50,000$828K0.0%N/A0.123%
5/17/2021Pinz Capital Management LP6,203$103K0.0%N/A0.015%
5/17/2021 Sphera Funds Management LTD.300,000$4.97M0.4%N/A0.739%
5/14/2021 Monashee Investment Management LLC125,000$2.07M0.3%N/A0.308%
5/12/2021 Pura Vida Investments LLC103,026$1.71M0.0%N/A0.254%
5/12/2021 JPMorgan Chase & Co.625,750$10.36M0.0%N/A1.540%
5/11/2021 Peregrine Capital Management LLC322,261$5.33M0.1%N/A0.793%
5/11/2021 Landscape Capital Management L.L.C.12,540$208K0.0%N/A0.031%
5/7/2021BlackRock Inc.25,000$413K0.0%N/A0.062%
(Data available from 1/1/2016 forward)

ACHL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ACHL shares?

During the previous two years, 13 institutional investors and hedge funds held shares of Achilles Therapeutics. The most heavily invested institutionals were BML Capital Management LLC ($4.18M), Fcpm Iii Services B.V. ($2.13M), Ikarian Capital LLC ($1.80M), StemPoint Capital LP ($1.73M), Baker BROS. Advisors LP ($1.51M), RA Capital Management L.P. ($1.45M), and Artal Group S.A. ($944K).Learn more on ACHL's institutional investors.

What percentage of Achilles Therapeutics stock is owned by institutional investors?

56.38% of Achilles Therapeutics stock is owned by institutional investors. Learn more on ACHL's institutional investor holdings.

Which institutional investors have been buying Achilles Therapeutics stock?

The following institutional investors have purchased Achilles Therapeutics stock in the last 24 months: BML Capital Management LLC ($3.47M), Fcpm Iii Services B.V. ($2.39M), Ikarian Capital LLC ($1.44M), StemPoint Capital LP ($1.39M), Acadian Asset Management LLC ($280.93K), Vestal Point Capital LP ($108.08K), and Forefront Analytics LLC ($45.10K).

How much institutional buying is happening at Achilles Therapeutics?

Institutional investors have bought a total of 9,164,362 shares in the last 24 months. This purchase volume represents approximately $9.73M in transactions.

Which Achilles Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Achilles Therapeutics stock in the last 24 months: RA Capital Management L.P. ($3.41M), Artal Group S.A. ($1.50M), Baker BROS. Advisors LP ($894.02K), Renaissance Technologies LLC ($323.03K), Acadian Asset Management LLC ($30.10K), and Virtu Financial LLC ($18.65K).

How much institutional selling is happening at Achilles Therapeutics?

Institutional investors have sold a total of 6,172,645 shares in the last 24 months. This volume of shares sold represents approximately $6.37M in transactions.



This page (NASDAQ:ACHL) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners